Evidence map›Paper›PMID 37723424›Full record

ArticleBMC neurology2023

Retinal functional and structural changes in patients with Parkinson's disease.

Rehab Elanwar, Hatem Al Masry, Amna Ibrahim, Mona Hussein, Sahar Ibrahim, Mohammed M Masoud

Open access · goldAbstract read
In one paragraph

Article in BMC neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Retinal Neurovascular Signatures in Parkinson's Disease.Investigative ophthalmology & visual science · 2025
    Article
  11. Article
  12. Brief report: effects of methylphenidate on the light adapted electroretinogram.Documenta ophthalmologica. Advances in ophthalmology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Is relying on RNFL specific enough to identify any changes in the CNS?Advances in ophthalmology practice and research
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Rehab ElanwarNeuro Diagnostic Research Center, Beni-Suef University, Beni-Suef, Egypt.
Hatem Al MasryDepartment of Neurology, Beni-Suef University, Salah Salem Street, Beni-Suef, Egypt.
Amna IbrahimDepartment of Neurology, Beni-Suef University, Salah Salem Street, Beni-Suef, Egypt.
Mona HusseinDepartment of Neurology, Beni-Suef University, Salah Salem Street, Beni-Suef, Egypt. mona.neuro@yahoo.com.ORCID http://orcid.org/0000-0002-7478-7008
Sahar IbrahimDepartment of Ophthalmology, Beni-Suef University, Beni-Suef, 62511, Egypt.
Mohammed M MasoudDepartment of Neurology, Beni-Suef University, Salah Salem Street, Beni-Suef, Egypt.
Beni-Suef University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVisual dysfunction have been well reported as one of the non-motor symptoms in Parkinson's disease (PD). The aim of this study was to evaluate the functional and structural changes in the retina in patients with PD, and to correlate these changes with disease duration and motor dysfunction.

methodsFor this case-control study, we recruited patients fulfilling the diagnostic criteria for idiopathic PD according to British Brain Bank criteria, aged between 50 and 80 years. Age- and sex-matched healthy controls aged between 50 and 80 years were also recruited. Motor function for PD patients was assessed using Modified Hoehn and Yahr staging scale (H & Y staging) and Unified Parkinson's Disease Rating Scale (UPDRS). Optical Coherence Tomography (OCT) and full field electroretinogram (ff-ERG) were done to all participants.

resultsData from 50 patients and 50 healthy controls were included in the analysis. Patients with idiopathic Parkinson's had significantly reduced peripapillary retinal nerve fiber layer (RNFL) thickness and macular ganglion cell complex (GCC) thickness compared to healthy controls (P-value < 0.05 in all parameters). They also had significantly delayed latency and reduced amplitude in both dark-adapted rods and the light-adapted cone for both a & b waves compared to healthy controls (P-value < 0.001 in all parameters). There were statistically significant negative correlations between disease duration, and left superior, right inferior and right & left average RNFL thickness [(r) coef. = -0.327, -0.301, -0.275, and -0.285 respectively]. UPDRS total score was negatively correlated with the amplitude of light-adapted of both RT and LT a & b wave and with dark-adapted RT b-wave latency [(r) coef. = -0.311, -0.395, -0.362, -0.419, and -0.342].

conclusionThe retinal structure and function were significantly affected in patients with PD in comparison to healthy controls. There was a significant impact of disease duration on retinal thickness, and there was a significant negative correlation between the degree of motor dysfunction in patients with PD and retinal function.

Indexed as

Parkinson DiseaseAgedAged, 80 and overBrainCase-Control StudiesElectroretinographyHumansMiddle AgedRetinaFull field electroretinogramMacular ganglion cell complexOptical coherence tomographyParkinson’s diseaseRetinal nerve fiber layer thickness

Identifiers

PMID37723424
PMCPMC10506234
OpenAlexW4386833413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.